SBRA (STOCKS)
Sabra Healthcare REIT, Inc.
$20.150000
-0.040000 (-0.20%)
Prev close: $20.190000
Company Information
- Exchange
- XNAS
- Sector
- Finance
- Industry
- Real Estate Investment Trusts
- CEO
- Richard K. Matros
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,145.02M
- Employees
- 50
- P/E (TTM)
- 77.62
- P/B (TTM)
- 1.88
- Dividend Yield
- 594.35%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
7
Buy
10
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.10 | $0.18 | -0.2763 | -156.72% |
|
Mar 2026 (Q1)
|
$0.16 | $0.17 | -0.0090 | -5.33% |
|
Dec 2025 (Q4)
|
$0.11 | $0.18 | -0.0663 | -37.61% |
|
Sep 2025 (Q3)
|
$0.09 | $0.19 | -0.0965 | -51.74% |
Financial Statements
| Revenues | $859.56M |
| Benefits Costs and Expenses | $799.21M |
| Costs And Expenses | $799.21M |
| Operating Expenses | $799.21M |
| Operating Income/Loss | $60.35M |
| Income/Loss Before Equity Method Investments | $60.35M |
| Income/Loss From Continuing Operations After Tax | $58.22M |
| Income/Loss From Continuing Operations Before Tax | $60.35M |
| Income/Loss From Equity Method Investments | $7.01M |
| Income Tax Expense/Benefit | $2.13M |
| Net Income/Loss | $65.23M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$212.00K |
| Net Income/Loss Attributable To Parent | $65.44M |
| Net Income/Loss Available To Common Stockholders, Basic | $65.44M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.25 |
| Diluted Earnings Per Share | $0.26 |
| Basic Average Shares | 494,815,611 |
| Diluted Average Shares | 502,217,196 |
| Assets | $5.51B |
| Current Assets | $5.51B |
| Noncurrent Assets | $0.00 |
| Liabilities | $2.76B |
| Current Liabilities | $2.76B |
| Noncurrent Liabilities | $0.00 |
| Long-term Debt | $2.63B |
| Equity | $2.75B |
| Equity Attributable To Noncontrolling Interest | $1.72M |
| Equity Attributable To Parent | $2.75B |
| Liabilities And Equity | $5.51B |
| Net Cash Flow From Operating Activities | $371.57M |
| Net Cash Flow From Operating Activities, Continuing | $371.57M |
| Net Cash Flow From Investing Activities | -$334.97M |
| Net Cash Flow From Investing Activities, Continuing | -$334.97M |
| Net Cash Flow From Financing Activities | $100.01M |
| Net Cash Flow From Financing Activities, Continuing | $100.01M |
| Exchange Gains/Losses | $75.00K |
| Net Cash Flow | $136.69M |
| Net Cash Flow, Continuing | $136.61M |
| Comprehensive Income/Loss | $73.36M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$212.00K |
| Comprehensive Income/Loss Attributable To Parent | $73.57M |
| Other Comprehensive Income/Loss | $8.13M |